vs
信诺（CI）与Meta Platforms（META）财务数据对比。点击上方公司名可切换其他公司
信诺的季度营收约是Meta Platforms的1.2倍（$72.5B vs $59.9B），Meta Platforms净利率更高（38.0% vs 1.8%，领先36.3%），Meta Platforms同比增速更快（23.8% vs 10.4%），过去两年Meta Platforms的营收复合增速更高（28.2% vs 12.5%）
信诺集团是总部位于美国康涅狄格州布卢姆菲尔德的跨国营利性医疗管理及保险企业。旗下保险子公司主营医疗、牙科、失能、人寿、意外保险及相关产品服务，多数产品通过雇主及其他团体渠道销售。
Meta Platforms是总部位于美国加利福尼亚州门洛帕克的跨国科技巨头，属于全球头部科技企业阵营。旗下运营Facebook、Instagram、WhatsApp、Messenger、Threads等多款知名社交媒体及通讯服务，同时开展自有及第三方站点广告业务，2023年广告收入占其总营收的97.8%。
CI vs META — 直观对比
营收规模更大
CI
是对方的1.2倍
$59.9B
营收增速更快
META
高出13.4%
10.4%
净利率更高
META
高出36.3%
1.8%
两年增速更快
META
近两年复合增速
12.5%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $72.5B | $59.9B |
| 净利润 | $1.3B | $22.8B |
| 毛利率 | 20.3% | 81.8% |
| 营业利润率 | 3.2% | 41.3% |
| 净利率 | 1.8% | 38.0% |
| 营收同比 | 10.4% | 23.8% |
| 净利润同比 | -17.1% | 9.3% |
| 每股收益（稀释后） | $4.64 | $8.87 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CIMETA
| Q4 25 | $72.5B | $59.9B | ||
| Q3 25 | $69.7B | $51.2B | ||
| Q2 25 | $67.2B | $47.5B | ||
| Q1 25 | $65.5B | $42.3B | ||
| Q4 24 | $65.6B | $48.4B | ||
| Q3 24 | $63.7B | $40.6B | ||
| Q2 24 | $60.5B | $39.1B | ||
| Q1 24 | $57.3B | $36.5B |
净利润CIMETA
| Q4 25 | $1.3B | $22.8B | ||
| Q3 25 | $2.0B | $2.7B | ||
| Q2 25 | $1.6B | $18.3B | ||
| Q1 25 | $1.4B | $16.6B | ||
| Q4 24 | $1.5B | $20.8B | ||
| Q3 24 | $825.0M | $15.7B | ||
| Q2 24 | $1.6B | $13.5B | ||
| Q1 24 | $-212.0M | $12.4B |
毛利率CIMETA
| Q4 25 | 20.3% | 81.8% | ||
| Q3 25 | 20.4% | 82.0% | ||
| Q2 25 | 20.7% | 82.1% | ||
| Q1 25 | 26.1% | 82.1% | ||
| Q4 24 | 25.3% | 81.7% | ||
| Q3 24 | 25.3% | 81.8% | ||
| Q2 24 | 26.5% | 81.3% | ||
| Q1 24 | 27.6% | 81.8% |
营业利润率CIMETA
| Q4 25 | 3.2% | 41.3% | ||
| Q3 25 | 3.7% | 40.1% | ||
| Q2 25 | 3.4% | 43.0% | ||
| Q1 25 | 3.0% | 41.5% | ||
| Q4 24 | 3.3% | 48.3% | ||
| Q3 24 | 4.0% | 42.7% | ||
| Q2 24 | 4.0% | 38.0% | ||
| Q1 24 | 3.9% | 37.9% |
净利率CIMETA
| Q4 25 | 1.8% | 38.0% | ||
| Q3 25 | 2.8% | 5.3% | ||
| Q2 25 | 2.4% | 38.6% | ||
| Q1 25 | 2.2% | 39.3% | ||
| Q4 24 | 2.3% | 43.1% | ||
| Q3 24 | 1.3% | 38.7% | ||
| Q2 24 | 2.7% | 34.5% | ||
| Q1 24 | -0.4% | 33.9% |
每股收益（稀释后）CIMETA
| Q4 25 | $4.64 | $8.87 | ||
| Q3 25 | $6.98 | $1.05 | ||
| Q2 25 | $5.71 | $7.14 | ||
| Q1 25 | $4.85 | $6.43 | ||
| Q4 24 | $5.01 | $7.96 | ||
| Q3 24 | $2.63 | $6.03 | ||
| Q2 24 | $5.45 | $5.16 | ||
| Q1 24 | $-0.97 | $4.71 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $8.7B | $81.6B |
| 总债务越低越好 | $30.9B | $58.7B |
| 股东权益账面价值 | $41.7B | $217.2B |
| 总资产 | $157.9B | $366.0B |
| 负债/权益比越低杠杆越低 | 0.74× | 0.27× |
8季度趋势，按日历期对齐
现金及短期投资CIMETA
| Q4 25 | $8.7B | $81.6B | ||
| Q3 25 | $6.9B | $44.4B | ||
| Q2 25 | $5.1B | $47.1B | ||
| Q1 25 | $9.1B | $70.2B | ||
| Q4 24 | $8.2B | $77.8B | ||
| Q3 24 | $6.8B | $70.9B | ||
| Q2 24 | $7.9B | $58.1B | ||
| Q1 24 | $9.5B | $58.1B |
总债务CIMETA
| Q4 25 | $30.9B | $58.7B | ||
| Q3 25 | $30.9B | — | ||
| Q2 25 | $26.5B | — | ||
| Q1 25 | $26.5B | — | ||
| Q4 24 | $28.9B | $28.8B | ||
| Q3 24 | $30.2B | $28.8B | ||
| Q2 24 | $30.2B | — | ||
| Q1 24 | $31.1B | — |
股东权益CIMETA
| Q4 25 | $41.7B | $217.2B | ||
| Q3 25 | $41.8B | $194.1B | ||
| Q2 25 | $40.2B | $195.1B | ||
| Q1 25 | $40.2B | $185.0B | ||
| Q4 24 | $41.0B | $182.6B | ||
| Q3 24 | $42.1B | $164.5B | ||
| Q2 24 | $41.3B | $156.8B | ||
| Q1 24 | $41.2B | $149.5B |
总资产CIMETA
| Q4 25 | $157.9B | $366.0B | ||
| Q3 25 | $157.9B | $303.8B | ||
| Q2 25 | $151.7B | $294.7B | ||
| Q1 25 | $150.7B | $280.2B | ||
| Q4 24 | $155.9B | $276.1B | ||
| Q3 24 | $157.6B | $256.4B | ||
| Q2 24 | $155.4B | $230.2B | ||
| Q1 24 | $153.1B | $222.8B |
负债/权益比CIMETA
| Q4 25 | 0.74× | 0.27× | ||
| Q3 25 | 0.74× | — | ||
| Q2 25 | 0.66× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.71× | 0.16× | ||
| Q3 24 | 0.72× | 0.18× | ||
| Q2 24 | 0.73× | — | ||
| Q1 24 | 0.75× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $6.1B | $36.2B |
| 自由现金流经营现金流 - 资本支出 | — | $14.8B |
| 自由现金流率自由现金流/营收 | — | 24.8% |
| 资本支出强度资本支出/营收 | — | 35.7% |
| 现金转化率经营现金流/净利润 | 4.83× | 1.59× |
| 过去12个月自由现金流最近4个季度 | — | $46.1B |
8季度趋势，按日历期对齐
经营现金流CIMETA
| Q4 25 | $6.1B | $36.2B | ||
| Q3 25 | $3.4B | $30.0B | ||
| Q2 25 | $-1.9B | $25.6B | ||
| Q1 25 | $1.9B | $24.0B | ||
| Q4 24 | $5.2B | $28.0B | ||
| Q3 24 | $46.0M | $24.7B | ||
| Q2 24 | $265.0M | $19.4B | ||
| Q1 24 | $4.8B | $19.2B |
自由现金流CIMETA
| Q4 25 | — | $14.8B | ||
| Q3 25 | — | $11.2B | ||
| Q2 25 | — | $9.0B | ||
| Q1 25 | — | $11.1B | ||
| Q4 24 | — | $13.6B | ||
| Q3 24 | — | $16.5B | ||
| Q2 24 | — | $11.2B | ||
| Q1 24 | — | $12.8B |
自由现金流率CIMETA
| Q4 25 | — | 24.8% | ||
| Q3 25 | — | 21.8% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 26.2% | ||
| Q4 24 | — | 28.0% | ||
| Q3 24 | — | 40.6% | ||
| Q2 24 | — | 28.7% | ||
| Q1 24 | — | 35.2% |
资本支出强度CIMETA
| Q4 25 | — | 35.7% | ||
| Q3 25 | — | 36.7% | ||
| Q2 25 | — | 34.8% | ||
| Q1 25 | — | 30.6% | ||
| Q4 24 | — | 29.8% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 20.9% | ||
| Q1 24 | — | 17.6% |
现金转化率CIMETA
| Q4 25 | 4.83× | 1.59× | ||
| Q3 25 | 1.73× | 11.07× | ||
| Q2 25 | -1.16× | 1.39× | ||
| Q1 25 | 1.36× | 1.44× | ||
| Q4 24 | 3.39× | 1.34× | ||
| Q3 24 | 0.06× | 1.58× | ||
| Q2 24 | 0.16× | 1.44× | ||
| Q1 24 | — | 1.56× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CI
| Network Pharmacy | $34.3B | 47% |
| Home Delivery And Specialty | $21.1B | 29% |
| Cigna Healthcare | $9.4B | 13% |
| Services | $4.5B | 6% |
| Other Pharmacy | $3.4B | 5% |
| Service Other | $144.0M | 0% |
META
| Advertising | $58.1B | 97% |
| Reality Labs | $955.0M | 2% |
| Service Other | $801.0M | 1% |
